Boryung Corporation

KOSE:A003850 Stock Report

Market Cap: ₩667.9b

Boryung Future Growth

Future criteria checks 2/6

Boryung is forecast to grow earnings and revenue by 12.1% and 12.4% per annum respectively. EPS is expected to grow by 10.9% per annum. Return on equity is forecast to be 11.4% in 3 years.

Key information

12.1%

Earnings growth rate

10.9%

EPS growth rate

Pharmaceuticals earnings growth33.3%
Revenue growth rate12.4%
Future return on equity11.4%
Analyst coverage

Low

Last updated06 Nov 2024

Recent future growth updates

Recent updates

We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Sep 20
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Aug 05
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Apr 06
Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Apr 28
A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Mar 17
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Feb 27
Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09
Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25
Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10
Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23
Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Earnings and Revenue Growth Forecasts

KOSE:A003850 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,312,00082,000N/A72,0001
12/31/20251,173,20069,800N/A70,0001
12/31/20241,041,00064,900N/A131,0001
9/30/2024991,43061,99557,03579,934N/A
6/30/2024928,71864,57940,05163,399N/A
3/31/2024889,41652,25451,61078,166N/A
12/31/2023859,62640,20319,16942,224N/A
9/30/2023829,85428,267-120,022-3,357N/A
6/30/2023819,46338,284-75,46743,689N/A
3/31/2023785,67942,063-94,39324,794N/A
12/31/2022760,47641,894-95,18127,814N/A
9/30/2022724,65953,9112,90966,442N/A
6/30/2022694,17052,524-37,85422,893N/A
3/31/2022661,94834,380-24,30137,032N/A
12/31/2021627,27943,04495760,167N/A
9/30/2021600,00841,82331,49351,816N/A
6/30/2021587,35028,892-1,69956,164N/A
3/31/2021571,59438,3704,51558,667N/A
12/31/2020561,86726,856-10,65544,741N/A
9/30/2020562,43327,744-7,87046,515N/A
6/30/2020546,97427,96925,01746,561N/A
3/31/2020539,74231,6789,93335,068N/A
12/31/2019524,26932,222-20,24646,999N/A
9/30/2019498,00632,950-31,14557,203N/A
6/30/2019480,24229,886-54,42945,294N/A
3/31/2019467,44522,830-55,63147,848N/A
12/31/2018460,40220,307-17,50738,914N/A
9/30/2018441,58064,630-45,28924,718N/A
6/30/2018440,08762,855N/A26,833N/A
3/31/2018434,56560,451N/A-12,386N/A
12/31/2017422,72156,699N/A-24,614N/A
9/30/2017426,554-3,202N/A-31,392N/A
6/30/2017423,777-2,977N/A-33,281N/A
3/31/2017420,1335,020N/A402N/A
12/31/2016409,1405,614N/A9,363N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A003850's forecast earnings growth (12.1% per year) is above the savings rate (2.7%).

Earnings vs Market: A003850's earnings (12.1% per year) are forecast to grow slower than the KR market (28.4% per year).

High Growth Earnings: A003850's earnings are forecast to grow, but not significantly.

Revenue vs Market: A003850's revenue (12.4% per year) is forecast to grow faster than the KR market (9.4% per year).

High Growth Revenue: A003850's revenue (12.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A003850's Return on Equity is forecast to be low in 3 years time (11.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y